According to the Mayo Clinic, about 20% of breast cancers make abnormally high levels of a protein called human epidermal growth factor receptor 2 (HER2).
When displayed on the surface of cancer cells, this signaling protein helps them proliferate uncontrollably and is linked with a poor prognosis. Now, researchers have developed a DNA nanorobot that recognizes HER2 on breast cancer cells, targeting them for destruction. They report their results in the ACS journal Nano Letters.
Current therapies for HER2-positive breast cancer include monoclonal antibodies, such as trastuzumab, that bind to HER2 on cells and direct it to the lysosome –– an organelle that degrades biomolecules. Lowering the levels of HER2 slows cancer cell proliferation and triggers cell death. Although monoclonal antibodies can lead to the death of cancer cells, they have severe side effects and are difficult and expensive to produce. In a previous study, Yunfeng Lin and colleagues identified a short sequence of DNA, called an aptamer, that recognizes and binds HER2, targeting it for lysosomal degradation in much the same way that monoclonal antibodies do. But the aptamer wasn’t very stable in serum. So the researchers wanted to see if adding a DNA nanostructure, called a tetrahedral framework nucleic acid (tFNA), could increase the aptamer’s biostability and anti-cancer activity.
To find out, the team designed DNA nanorobots consisting of the tFNA with an attached HER2 aptamer. When injected into mice, the nanorobots persisted in the bloodstream more than twice as long as the free aptamer. Next, the researchers added nanorobots to three breast cancer cell lines in petri dishes, showing that they killed only the HER2-positive cell line. The addition of the tFNA allowed more of the aptamer to bind to HER2 than without tFNA, leading to reduced HER2 levels on cell surfaces. Although the nanorobot is much easier and less expensive to make than monoclonal antibodies, it likely needs further improvement before it could be used to treat breast cancer in the clinic, the researchers say.
The Latest on: DNA nanorobot
via Google News
The Latest on: DNA nanorobot
- Nanorobotics Market Size Poised to Touch USD 12.72 billion by 2027on February 23, 2021 at 11:28 pm
Also, in February 2020, Researchers form the ITMO University announced their concept of treating cancer by nanorobot made of DNA fragments which can not only destroy the cancer cells but also locate ...
- Nuclease resistance of DNA nanostructureson February 10, 2021 at 3:56 am
DNA nanotechnology has progressed from proof-of-concept demonstrations of structural design towards application-oriented research. As a natural material with excellent self-assembling properties ...
- A cargo-sorting DNA roboton February 3, 2021 at 4:00 pm
Present address: Inria, Paris, France. See allHide authors and affiliations Single-stranded DNA robots can move over the surface of a DNA origami sheet and sort molecular cargoes. Thubagere et al.
- An orthogonally regulatable DNA nanodevice for spatiotemporally controlled biorecognition and tumor treatmenton February 3, 2021 at 4:00 pm
For example, an aptamer-based DNA nanorobot permitted specific transport of molecular payloads to cancer cells in response to membrane epitopes (19). An aptamer-tethered DNA nanotrain was explored for ...
- Three-Dimensional Structures Self-Assembled from DNA Brickson February 2, 2021 at 4:00 pm
See allHide authors and affiliations We describe a simple and robust method to construct complex three-dimensional (3D) structures by using short synthetic DNA strands that we call “DNA bricks.” In ...
- DNA-Based Robot Could Eventually Find Use in Therapeutic Deviceson January 31, 2021 at 4:00 pm
A molecular nanorobot (dyed green) moves on a DNA origami scaffold toward its goal (dyed red) by cleaving the visited substrates. Such DNA robots could eventually be used in therapeutic devices.
- What are nanobots?on April 3, 2019 at 9:28 am
DNA origami and beyond. A) DNA octahedron that inspired development ... than generate physical motion of their components at a nanoscale level. To build a true nanorobot – a completely self-contained ...
- Nanomedicine: the next breakthrough in oncology?on April 23, 2018 at 3:08 am
while the latter is a single-strand DNA (an aptamer) that targets nucleolin, a protein which is found in abundance and only in the endothelial cells lining blood vessels of tumours. Once the nanorobot ...
via Bing News